Slingshot members are tracking this event:

Phase 1 Clinical Trial for ATI-50001 Initiated, an Investigational JAK Inhibitor, for the Treatment of Alopecia Totalis and Alopecia Universalis

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
ACRS Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 07, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Ati-50001, Jak Inhibitor, Alopecia Areata, Ati-50002